Sangathi

News in the interests of the Global Tamils

Zydus begins human trials for potential coronavirus vaccine


Zydus has said it has started human studies for its potential coronavirus vaccine. In its human trials, Zydus will enrol over 1,000 subjects.

(Reuters illustration)

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential COVID-19 vaccine, as coronavirus infections continue to surge in the world’s third worst-hit nation.

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and well-tolerated in the pre-clinical toxicity studies, Zydus said.

In the human trials, Zydus will enrol over 1,000 subjects across multiple clinical study sites in India.


Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: